Holen Sie sich die Stockscreener-App
0.279
3.79%
-0.011
AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten
Aeon Biopharma, Inc. Receives Fda Type 2B Meeting Feedback Clarifying Biosimilar Development Plan for Abp-450 - marketscreener.com
Lake Street Maintains AEON Biopharma(AEON.US) With Buy Rating, Maintains Target Price $1 - Moomoo
AEON Biopharma, Inc. Stock Price Prediction: Today, Tomorrow, Next Week (AEON) - Traders Union
AEON Biopharmato Return to FDA in 2027 Wit - Moomoo
AEON Biopharma advances ABP-450 biosimilar development strategy - TipRanks
AEON Biopharma FDA Type 2b Meeting Feedback Clarifies Biosimilar Development Plan for ABP-450 - The Manila Times
AEON Biopharma receives FDA Type 2b minutes; plans IND for CMAP PD study, warrants to accelerate - TradingView
A 45-day expiry clock applies to AEON Biopharma (AEON) milestone warrants unless exercised. - Stock Titan
Live AEON Biopharma, Inc. (AEON) Technical Analysis - Traders Union
AEON Biopharma, Inc. (AEON) Earnings Date, Reports and Estimates - Traders Union
AEON Biopharma (AEON) Ticks Up to $0.26 as Sub-$1 Micro-Cap Defends $0.25 SupportSkew Index - siam.in
$AEON Biopharma (AEON.US)$ following choch - Moomoo
AEON Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Stock SlidesEPS Guidance Update - careplusvn.com
AEON Biopharma, Inc. Stock Price Today | AEON Live Chart & News - Traders Union
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$AEON Biopharma (AEON.US)$ 1 choch, 2 choch, last major choch almost ✔️ and consolidation over. - Moomoo
$AEON Biopharma (AEON.US)$ - Moomoo
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Biotech Pre-Market Movers: TNON, AEON Surge; COO, CDT Slide - RTTNews
$AEON Biopharma (AEON.US)$ interesting. got it marked from 2025 not sure why lmao - Moomoo
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
The rocket is about to launch 😘 - Moomoo
Laidlaw initiates Aeon Biopharma stock coverage with buy rating By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
$AEON Biopharma (AEON.US)$ goshhh.. 😅 - Moomoo
Aeon Claims Drug Holds Up Against Botox in Stress Test - Orange County Business Journal
AEON Biopharma, Inc. Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of Abp-450 to Botox - marketscreener.com
AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX - marketscreener.com
BOTOX and ABP-450 each fell to about half strength by day 14 - Stock Titan
Laidlaw initiates Aeon Biopharma stock coverage with buy rating - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference - The Manila Times
AEON Biopharma to Host Investor Meetings at Lake Street Capital Markets’ 10th Annual BIG10 Conference - quiverquant.com
AEON Biopharma (AEON) Surges 6.91% to $0.31, Nears Key Resistance at $0.33Low Volatility Picks - dars.gov.et
AEON Q2 2026 Earnings: Clinical-Stage Biotech Delivers Narrow EPS BeatFinancial Data - dars.gov.et
Insider Purchase: 10% Owner at $AEON Buys 1,150,000 Shares - Moomoo
AEON Biopharma names Paul Lee as acting chief regulatory officer By Investing.com - Investing.com Nigeria
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer - The Manila Times
AEON (AEON) Price: Moves 0.52% Down to $0.19 in Latest Trading; Price Levels: Price Remains Between $0.18 Support and $0.20 Resistance under the Current SnapshotMcClellan Oscillator - careplusvn.com
Aeon Biopharma director Timothy Lynch buys $243,455 in stock By Investing.com - Investing.com India
Aeon Biopharma director Timothy Lynch buys $243,455 in stock - Investing.com
Timothy Lynch (NASDAQ: AEON) owns 13% and holds blocked warrants - Stock Titan
AEON Reports New Data on Botox Biosimilar - Orange County Business Journal
AEON Flat on BOTOX Developments - Baystreet.ca
META_TITLE_QUOTE - Yahoo Finance
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX® - The Manila Times
AEON Biopharma (AEON) Steadies at $0.28 as Key Support HoldsVolume Gap - vinanet.vn
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution - Investing.com
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution By Investing.com - Investing.com UK
AEON Biopharma (AEON) Holds Above $0.27 Support as Shares Edge Up 1.66%Extension Target - vinanet.vn
AEON Q4 2025 Earnings: Wider-than-Expected Loss of -$0.42 per Share as Revenue Remains Absent - vinanet.vn
H.C. Wainwright Maintains AEON Biopharma(AEON.US) With Buy Rating, Cuts Target Price to $1.2 - Moomoo
AEON Biopharma Q2 EPS $(0.02) beats $(0.12) estimate - scanx.trade
AEON Biopharma Reports Q2 Results, Advances ABP-450 Program - TipRanks
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma Q2 net loss narrows on warrant gain; cash runway extended - TradingView
0.05%
0.82%
Kapitalisierung:
|
Volumen (24h):